Merck & Co : after Vioxx, the government and the pharmaceutical industry reconsider the balance between innovation, safety, and cost - Elias, Jaan, (SAGE, 2016)
Originally Published in: Elias, J., Hutchins, S., & Nagy, A. (2006). Merck & Co. After Vioxx, the Government and the Pharmaceutical Industry Reconsider the Balance between Innovation, Safety, and Cost. 06-013. New Haven, CT: Yale School of Management, Yale University.